Zbigniew Zaslona

Company: Molecure

Job title: CSO

Seminars:

Examining OATD-01- A First-in-Class Chitnase Inhibitor’s MOA in Lung Sarcoidosis to Unveil Potential in Other ILDs 3:45 pm

• Dive into the mechanism of action a first-in-class chitnase inhibitor • Explore the potential of OATD-01, currently in Phase 2, to address a wider range of ILDsRead more

day: Day Two